应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
MRKR Marker Therapeutics, Inc.
已收盘 04-22 16:00:00 EDT
1.19
-0.01
-0.83%
盘后
1.17
-0.02
-1.68%
19:13 EDT
最高
1.25
最低
1.19
成交量
4.17万
今开
1.20
昨收
1.20
日振幅
5.29%
总市值
1,274万
流通市值
776.48万
总股本
1,071万
成交额
5.02万
换手率
0.64%
流通股本
652.50万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Marker Therapeutics, Inc.盘中异动 股价大涨5.22%报1.21美元
市场透视 · 04-21 16:16
Marker Therapeutics, Inc.盘中异动 股价大涨5.22%报1.21美元
Marker Therapeutics, Inc.盘中异动 下午盘股价大跌5.13%
市场透视 · 04-16
Marker Therapeutics, Inc.盘中异动 下午盘股价大跌5.13%
Marker Therapeutics, Inc.盘中异动 早盘股价大涨6.36%
市场透视 · 04-15
Marker Therapeutics, Inc.盘中异动 早盘股价大涨6.36%
Marker Therapeutics, Inc.盘中异动 早盘急速拉升5.33%报1.58美元
市场透视 · 03-10
Marker Therapeutics, Inc.盘中异动 早盘急速拉升5.33%报1.58美元
Marker Therapeutics, Inc.盘中异动 早盘股价大涨9.42%报1.51美元
市场透视 · 03-05
Marker Therapeutics, Inc.盘中异动 早盘股价大涨9.42%报1.51美元
Marker Therapeutics(MRKR.US)获加拿大投资银行集团首次覆盖,给予买入评级, 目标价8.00美元。
金融界 · 03-05
Marker Therapeutics(MRKR.US)获加拿大投资银行集团首次覆盖,给予买入评级, 目标价8.00美元。
Marker Therapeutics, Inc.盘中异动 股价大涨5.23%报1.61美元
市场透视 · 02-27
Marker Therapeutics, Inc.盘中异动 股价大涨5.23%报1.61美元
Marker Therapeutics, Inc.盘中异动 早盘快速跳水5.52%报1.48美元
市场透视 · 02-24
Marker Therapeutics, Inc.盘中异动 早盘快速跳水5.52%报1.48美元
Marker Therapeutics, Inc.盘中异动 快速跳水5.52%
市场透视 · 02-21
Marker Therapeutics, Inc.盘中异动 快速跳水5.52%
Marker Therapeutics, Inc.盘中异动 急速拉升8.18%
市场透视 · 02-13
Marker Therapeutics, Inc.盘中异动 急速拉升8.18%
Marker Therapeutics, Inc.盘中异动 早盘股价大涨7.47%
市场透视 · 02-10
Marker Therapeutics, Inc.盘中异动 早盘股价大涨7.47%
Marker Therapeutics, Inc.盘中异动 早盘急速跳水5.20%
市场透视 · 02-06
Marker Therapeutics, Inc.盘中异动 早盘急速跳水5.20%
Marker Therapeutics, Inc.盘中异动 早盘股价大涨5.94%
市场透视 · 02-05
Marker Therapeutics, Inc.盘中异动 早盘股价大涨5.94%
Marker Therapeutics, Inc.盘中异动 临近收盘快速拉升5.03%报1.88美元
市场透视 · 02-04
Marker Therapeutics, Inc.盘中异动 临近收盘快速拉升5.03%报1.88美元
Marker Therapeutics, Inc.盘中异动 股价大跌9.07%
市场透视 · 02-03
Marker Therapeutics, Inc.盘中异动 股价大跌9.07%
Marker Therapeutics, Inc.盘中异动 早盘快速拉升9.03%报2.10美元
市场透视 · 01-30
Marker Therapeutics, Inc.盘中异动 早盘快速拉升9.03%报2.10美元
Marker Therapeutics, Inc.盘中异动 临近午盘股价大跌5.14%
市场透视 · 01-27
Marker Therapeutics, Inc.盘中异动 临近午盘股价大跌5.14%
Marker Therapeutics, Inc.盘中异动 早盘大幅上涨5.05%报2.27美元
市场透视 · 01-23
Marker Therapeutics, Inc.盘中异动 早盘大幅上涨5.05%报2.27美元
Marker Therapeutics, Inc.盘中异动 股价大跌5.26%
市场透视 · 01-17
Marker Therapeutics, Inc.盘中异动 股价大跌5.26%
Marker Therapeutics, Inc.盘中异动 早盘大幅下挫5.09%
市场透视 · 01-16
Marker Therapeutics, Inc.盘中异动 早盘大幅下挫5.09%
加载失败,点击重试
公司概况
公司名称:
Marker Therapeutics, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Marker Therapeutics, Inc.是一家临床阶段的免疫肿瘤学公司,专门开发下一代T细胞免疫疗法,用于治疗血液系统恶性肿瘤和实体肿瘤适应症。 Marker的细胞治疗技术基于非工程化的肿瘤特异性T细胞的选择性扩增,其识别肿瘤相关抗原(即肿瘤靶标)并杀死表达这些靶标的肿瘤细胞。一旦输入患者,这组T细胞攻击多个肿瘤靶标并起到激活患者免疫系统的作用,以产生广谱抗肿瘤活性。由于Marker不对其T细胞进行基因工程改造,因此与目前基于CAR-T和TCR的工程方法相比,其产品(i)的成本更低,更容易制造,(ii)毒性明显降低,( iii)与有意义的临床益处相关。因此,与当前基因修饰的CAR-T和基于TCR的疗法相比,Marker认为其T细胞疗法组合具有引人注目的治疗产品特征。
发行价格:
--
{"stockData":{"symbol":"MRKR","market":"US","secType":"STK","nameCN":"Marker Therapeutics, Inc.","latestPrice":1.19,"timestamp":1745352000000,"preClose":1.2,"halted":0,"volume":41664,"hourTrading":{"tag":"盘后","latestPrice":1.17,"preClose":1.19,"latestTime":"19:13 EDT","volume":512,"amount":599.04,"timestamp":1745363581056},"delay":0,"floatShares":6525034,"shares":10709005,"eps":-1.194996,"marketStatus":"已收盘","change":-0.01,"latestTime":"04-22 16:00:00 EDT","open":1.2,"high":1.25,"low":1.1865,"amount":50227.9977024,"amplitude":0.052917,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.194996,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1745395200000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":1.2,"preHourTrading":{"tag":"盘前","latestPrice":1.2,"preClose":1.2,"latestTime":"09:25 EDT","volume":41,"amount":49.199999999999996,"timestamp":1745328332756},"postHourTrading":{"tag":"盘后","latestPrice":1.17,"preClose":1.19,"latestTime":"19:13 EDT","volume":512,"amount":599.04,"timestamp":1745363581056},"volumeRatio":1.06465,"impliedVol":5.7071,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/MRKR/tweets","defaultTab":"tweets","newsList":[{"id":"2529938717","title":"Marker Therapeutics, Inc.盘中异动 股价大涨5.22%报1.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529938717","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529938717?lang=zh_cn&edition=full","pubTime":"2025-04-22 00:16","pubTimestamp":1745252169,"startTime":"0","endTime":"0","summary":"北京时间2025年04月22日00时16分,Marker Therapeutics, Inc.股票出现异动,股价快速拉升5.22%。Marker Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.15%。Marker Therapeutics, Inc.公司简介:Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤学公司,专门从事用于治疗血液系统恶性肿瘤和实体瘤适应症的新型基于 T 细胞的免疫疗法和基于肽的疫苗的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042200161094dd0c47&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042200161094dd0c47&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRKR","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2528278431","title":"Marker Therapeutics, Inc.盘中异动 下午盘股价大跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2528278431","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528278431?lang=zh_cn&edition=full","pubTime":"2025-04-17 01:37","pubTimestamp":1744825020,"startTime":"0","endTime":"0","summary":"北京时间2025年04月17日01时37分,Marker Therapeutics, Inc.股票出现波动,股价快速下挫5.13%。Marker Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为1.20%。Marker Therapeutics, Inc.公司简介:Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤学公司,专门从事用于治疗血液系统恶性肿瘤和实体瘤适应症的新型基于 T 细胞的免疫疗法和基于肽的疫苗的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041701370094d7b27f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041701370094d7b27f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","MRKR","BK4139"],"gpt_icon":0},{"id":"2527449996","title":"Marker Therapeutics, Inc.盘中异动 早盘股价大涨6.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527449996","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527449996?lang=zh_cn&edition=full","pubTime":"2025-04-15 23:04","pubTimestamp":1744729462,"startTime":"0","endTime":"0","summary":"北京时间2025年04月15日23时04分,Marker Therapeutics, Inc.股票出现异动,股价快速拉升6.36%。Marker Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.06%。Marker Therapeutics, Inc.公司简介:Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司,专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化,用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415230423a459dda0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415230423a459dda0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4139","MRKR"],"gpt_icon":0},{"id":"2518203028","title":"Marker Therapeutics, Inc.盘中异动 早盘急速拉升5.33%报1.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518203028","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518203028?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:34","pubTimestamp":1741613645,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时34分,Marker Therapeutics, Inc.股票出现异动,股价快速拉升5.33%。Marker Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.01%。Marker Therapeutics, Inc.公司简介:Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司,专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化,用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213405a26a25aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213405a26a25aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","MRKR"],"gpt_icon":0},{"id":"2517948357","title":"Marker Therapeutics, Inc.盘中异动 早盘股价大涨9.42%报1.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517948357","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517948357?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:32","pubTimestamp":1741185126,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时32分,Marker Therapeutics, Inc.股票出现波动,股价急速上涨9.42%。Marker Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.20%。Marker Therapeutics, Inc.公司简介:Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司,专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化,用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223206a260c78a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223206a260c78a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRKR","LENZ","BK4139"],"gpt_icon":0},{"id":"2517997902","title":"Marker Therapeutics(MRKR.US)获加拿大投资银行集团首次覆盖,给予买入评级, 目标价8.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517997902","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517997902?lang=zh_cn&edition=full","pubTime":"2025-03-05 18:56","pubTimestamp":1741172193,"startTime":"0","endTime":"0","summary":"Marker Therapeutics(MRKR.US)获加拿大投资银行集团首次覆盖,给予买入评级, 目标价8.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/05185648544417.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","MRKR"],"gpt_icon":0},{"id":"2514334834","title":"Marker Therapeutics, Inc.盘中异动 股价大涨5.23%报1.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514334834","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514334834?lang=zh_cn&edition=full","pubTime":"2025-02-28 03:26","pubTimestamp":1740684361,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日03时26分,Marker Therapeutics, Inc.股票出现波动,股价大幅上涨5.23%。Marker Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.10%。Marker Therapeutics, Inc.公司简介:Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司,专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化,用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280326019895468b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280326019895468b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MRKR","LENZ"],"gpt_icon":0},{"id":"2514773003","title":"Marker Therapeutics, Inc.盘中异动 早盘快速跳水5.52%报1.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514773003","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514773003?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:57","pubTimestamp":1740412640,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时57分,Marker Therapeutics, Inc.股票出现异动,股价快速下跌5.52%。Marker Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.15%。Marker Therapeutics, Inc.公司简介:Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司,专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化,用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224235720abdb2246&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224235720abdb2246&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRKR","LENZ","BK4139"],"gpt_icon":0},{"id":"2513211213","title":"Marker Therapeutics, Inc.盘中异动 快速跳水5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513211213","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513211213?lang=zh_cn&edition=full","pubTime":"2025-02-22 03:36","pubTimestamp":1740166584,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日03时36分,Marker Therapeutics, Inc.股票出现波动,股价快速下挫5.52%。Marker Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.48%。Marker Therapeutics, Inc.公司简介:Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司,专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化,用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222033624962bbc90&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222033624962bbc90&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRKR","BK4139","LENZ"],"gpt_icon":0},{"id":"2511574215","title":"Marker Therapeutics, Inc.盘中异动 急速拉升8.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511574215","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511574215?lang=zh_cn&edition=full","pubTime":"2025-02-14 04:19","pubTimestamp":1739477980,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日04时19分,Marker Therapeutics, Inc.股票出现波动,股价大幅拉升8.18%。Marker Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.18%。Marker Therapeutics, Inc.公司简介:Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司,专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化,用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021404194098846fa4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021404194098846fa4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRKR","LENZ","BK4139"],"gpt_icon":0},{"id":"2510286372","title":"Marker Therapeutics, Inc.盘中异动 早盘股价大涨7.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510286372","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510286372?lang=zh_cn&edition=full","pubTime":"2025-02-10 22:35","pubTimestamp":1739198126,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日22时35分,Marker Therapeutics, Inc.股票出现波动,股价急速上涨7.47%。Marker Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.23%。Marker Therapeutics, Inc.公司简介:Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司,专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化,用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223527961e00ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223527961e00ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","MRKR","BK4139"],"gpt_icon":0},{"id":"2509205868","title":"Marker Therapeutics, Inc.盘中异动 早盘急速跳水5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509205868","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509205868?lang=zh_cn&edition=full","pubTime":"2025-02-07 00:00","pubTimestamp":1738857623,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日00时00分,Marker Therapeutics, Inc.股票出现波动,股价快速下跌5.20%。Marker Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.11%。Marker Therapeutics, Inc.公司简介:Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司,专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化,用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207000023a23be246&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207000023a23be246&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MRKR","LENZ"],"gpt_icon":0},{"id":"2509380062","title":"Marker Therapeutics, Inc.盘中异动 早盘股价大涨5.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509380062","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509380062?lang=zh_cn&edition=full","pubTime":"2025-02-05 23:37","pubTimestamp":1738769837,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日23时37分,Marker Therapeutics, Inc.股票出现波动,股价大幅上涨5.94%。Marker Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.35%。Marker Therapeutics, Inc.公司简介:Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司,专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化,用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205233717abc38c2b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205233717abc38c2b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","MRKR","BK4139"],"gpt_icon":0},{"id":"2509491992","title":"Marker Therapeutics, Inc.盘中异动 临近收盘快速拉升5.03%报1.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509491992","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509491992?lang=zh_cn&edition=full","pubTime":"2025-02-05 04:49","pubTimestamp":1738702198,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日04时49分,Marker Therapeutics, Inc.股票出现异动,股价大幅拉升5.03%。Marker Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.51%。Marker Therapeutics, Inc.公司简介:Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司,专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化,用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205044959987a842f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205044959987a842f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRKR","LENZ","BK4139"],"gpt_icon":0},{"id":"2508144355","title":"Marker Therapeutics, Inc.盘中异动 股价大跌9.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508144355","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508144355?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:45","pubTimestamp":1738593941,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时45分,Marker Therapeutics, Inc.股票出现波动,股价大幅下跌9.07%。Marker Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.35%。Marker Therapeutics, Inc.公司简介:Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司,专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化,用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203224542987971a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203224542987971a3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MRKR","LENZ"],"gpt_icon":0},{"id":"2507624413","title":"Marker Therapeutics, Inc.盘中异动 早盘快速拉升9.03%报2.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507624413","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507624413?lang=zh_cn&edition=full","pubTime":"2025-01-30 22:47","pubTimestamp":1738248457,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日22时47分,Marker Therapeutics, Inc.股票出现异动,股价快速上涨9.03%。Marker Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.07%。Marker Therapeutics, Inc.公司简介:Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司,专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化,用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501302247389876b3ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501302247389876b3ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","MRKR","BK4139"],"gpt_icon":0},{"id":"2506168302","title":"Marker Therapeutics, Inc.盘中异动 临近午盘股价大跌5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506168302","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506168302?lang=zh_cn&edition=full","pubTime":"2025-01-28 00:46","pubTimestamp":1737996380,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日00时46分,Marker Therapeutics, Inc.股票出现异动,股价快速下挫5.14%。Marker Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.95%。Marker Therapeutics, Inc.公司简介:Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司,专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化,用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128004621abba7c34&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128004621abba7c34&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","MRKR","BK4139"],"gpt_icon":0},{"id":"2505043909","title":"Marker Therapeutics, Inc.盘中异动 早盘大幅上涨5.05%报2.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505043909","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505043909?lang=zh_cn&edition=full","pubTime":"2025-01-24 00:12","pubTimestamp":1737648735,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日00时12分,Marker Therapeutics, Inc.股票出现波动,股价大幅拉升5.05%。Marker Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.19%。Marker Therapeutics, Inc.公司简介:Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司,专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化,用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124001216abb60ffe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124001216abb60ffe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","MRKR"],"gpt_icon":0},{"id":"2504112815","title":"Marker Therapeutics, Inc.盘中异动 股价大跌5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2504112815","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504112815?lang=zh_cn&edition=full","pubTime":"2025-01-18 04:48","pubTimestamp":1737146902,"startTime":"0","endTime":"0","summary":"北京时间2025年01月18日04时48分,Marker Therapeutics, Inc.股票出现异动,股价快速下挫5.26%。Marker Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.46%。Marker Therapeutics, Inc.公司简介:Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司,专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化,用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501180448239607e35f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501180448239607e35f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MRKR","LENZ"],"gpt_icon":0},{"id":"2503913982","title":"Marker Therapeutics, Inc.盘中异动 早盘大幅下挫5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503913982","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503913982?lang=zh_cn&edition=full","pubTime":"2025-01-16 22:51","pubTimestamp":1737039101,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日22时51分,Marker Therapeutics, Inc.股票出现波动,股价快速跳水5.09%。Marker Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.73%。Marker Therapeutics, Inc.公司简介:Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司,专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化,用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116225141abad548d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116225141abad548d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","MRKR","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.markertherapeutics.com","stockEarnings":[{"period":"1week","weight":0.0909},{"period":"1month","weight":-0.04},{"period":"3month","weight":-0.4146},{"period":"6month","weight":-0.7339},{"period":"1year","weight":-0.7101},{"period":"ytd","weight":-0.6141}],"compareEarnings":[{"period":"1week","weight":-0.0468},{"period":"1month","weight":-0.0888},{"period":"3month","weight":-0.1479},{"period":"6month","weight":-0.1109},{"period":"1year","weight":0.0378},{"period":"ytd","weight":-0.1232}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Marker Therapeutics, Inc.是一家临床阶段的免疫肿瘤学公司,专门开发下一代T细胞免疫疗法,用于治疗血液系统恶性肿瘤和实体肿瘤适应症。 Marker的细胞治疗技术基于非工程化的肿瘤特异性T细胞的选择性扩增,其识别肿瘤相关抗原(即肿瘤靶标)并杀死表达这些靶标的肿瘤细胞。一旦输入患者,这组T细胞攻击多个肿瘤靶标并起到激活患者免疫系统的作用,以产生广谱抗肿瘤活性。由于Marker不对其T细胞进行基因工程改造,因此与目前基于CAR-T和TCR的工程方法相比,其产品(i)的成本更低,更容易制造,(ii)毒性明显降低,( iii)与有意义的临床益处相关。因此,与当前基因修饰的CAR-T和基于TCR的疗法相比,Marker认为其T细胞疗法组合具有引人注目的治疗产品特征。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.069516},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.076427},{"month":3,"riseRate":0.444444,"avgChangeRate":-0.080323},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.001609},{"month":5,"riseRate":0.5,"avgChangeRate":0.232573},{"month":6,"riseRate":0.625,"avgChangeRate":0.292775},{"month":7,"riseRate":0.125,"avgChangeRate":-0.07757},{"month":8,"riseRate":0.375,"avgChangeRate":0.002117},{"month":9,"riseRate":0.25,"avgChangeRate":-0.071254},{"month":10,"riseRate":0.375,"avgChangeRate":-0.038018},{"month":11,"riseRate":0.25,"avgChangeRate":-0.08549},{"month":12,"riseRate":0.222222,"avgChangeRate":0.037661}],"exchange":"NASDAQ","name":"Marker Therapeutics, Inc.","nameEN":"Marker Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Marker Therapeutics, Inc.(MRKR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Marker Therapeutics, Inc.(MRKR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Marker Therapeutics, Inc.,MRKR,Marker Therapeutics, Inc.股票,Marker Therapeutics, Inc.股票老虎,Marker Therapeutics, Inc.股票老虎国际,Marker Therapeutics, Inc.行情,Marker Therapeutics, Inc.股票行情,Marker Therapeutics, Inc.股价,Marker Therapeutics, Inc.股市,Marker Therapeutics, Inc.股票价格,Marker Therapeutics, Inc.股票交易,Marker Therapeutics, Inc.股票购买,Marker Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Marker Therapeutics, Inc.(MRKR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Marker Therapeutics, Inc.(MRKR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}